Anna Berkenblit, VP & Chief Medical Officer at IMMUNOGEN INC (IMGN), sold 5,851 shares at $8.00 ($47K) on 2018-10-16, disclosed to the SEC on 2018-10-17.
Scheduled sale ($47k) by VP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IMGN | SELL | 2018-09-11 | $111K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $377K | — | Filing → |
| IMGN | SELL | 2017-09-18 | $11K | — | Filing → |